Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX

Drug identity checked against registry records

Also recorded as 5-Fluracil; Abraxane; Camptosar; Efudex; Eloxitan; FG-3019; Gemzar; Leucovorin

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.